Rethinking atherogenic risk: is apolipoprotein B a better biomarker?Giuseppe Lippion May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0624. Online ahead of print. NO ABSTRACT PMID:42106163 | DOI:10.1515/cclm-2026-0624
ccinfoadmin
Limitations to the development of Milan model 1b analytical performance specificationsGraham Ross Dallas Joneson May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0377. Online ahead of print. ABSTRACT A widely accepted approach to setting Analytical Performance Specifications (APS) in laboratory medicine is the Milan models. Milan model 1b is an approach where APS are developed based on patient classification, or clinical decision-making, noting that these factors link to the … Read more
Factors associated with analytical errors in blood chemistry testsHyunjung Kimon May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0153. Online ahead of print. ABSTRACT OBJECTIVES: Few studies have systematically evaluated the factors contributing to laboratory errors in the analytical phase. This study analyzed five years of retest data to determine the frequency and characteristics of analytical errors across routine blood chemistry parameters, identify analytes most … Read more
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritison May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Hiroki Kobayashi, Yusuke Murata, Yurie Akiya, Tomomi Matsuoka, Hiromasa Otsuka, Akiko Tsunemi, Yoshihiro Nakamura, Masaki Azuma, Masanori Abe
Exploring the role of circulating glial fibrillary acidic protein and neurofilament light chain in myasthenia gravison May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Caterina Maria Gambino, Luisa Agnello, Concetta Scazzone, Martina Tamburello, Anna Masucci, Roberta Vassallo, Vincenzo Di Stefano, Filippo Brighina, Marcello Ciaccio
Chemical and biochemical derivates of trans-3-methylglutaconyl CoA: A molecular labyrinthon May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Elizabeth A. Jennings, Dylan E. Jones, Robert O. Ryan
Serial monitoring of cytokine profile, liver function, and hematological biomarkers in severe CRS and CLS following CAR-T cell therapy for relapsed hepatocellular carcinoma: a case reporton May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Minle Wu, Wei Guo, Beili Wang, Meixiu Gu, Chong Wang
Rapid and highly sensitive detection of MYD88/CXCR4 mutations in Waldenström macroglobulinemia by MAS-qPCR: A pilot studyon May 11, 2026 at 2:32 pm
Publication date: August 2026 Source: Clinical Biochemistry, Volume 144 Author(s): Yuki Kunimune, Mitsuaki Nishioka, Haruka Namba, Kimika Todaka, Tomohiro Fujii, Nayu Kiso, Yukiko Nakahara, Kanae Shinkawa, Yumiko Kumano, Masaki Kodama, Tomoya Ebisui, Ryoga Nishimoto, Naoko Okayama, Yutaka Suehiro, Takahiro Yamasaki, Toshiaki Yujiri
Analytical performance evaluation and method comparison of the 1copy BCR::ABL1 qPCR assay for monitoring chronic myeloid leukemiaon May 11, 2026 at 2:32 pm
Publication date: Available online 9 May 2026 Source: Practical Laboratory Medicine Author(s): Hyerin Kim, Do Young Kim, Hyerim Kim
Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance
Clin Chem. 2026 May 7:hvag042. doi: 10.1093/clinchem/hvag042. Online ahead of print. NO ABSTRACT PMID:42096656 | DOI:10.1093/clinchem/hvag042